MiMedx Group
MDXG
153 hedge funds and large institutions have $214M invested in MiMedx Group in 2022 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 31 increasing their positions, 53 reducing their positions, and 13 closing their positions.
54% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 13
2% more funds holding
Funds holding: 150 → 153 (+3)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0.48% less ownership
Funds ownership: 54.79% → 54.31% (-0.48%)
16% less call options, than puts
Call options by funds: $347K | Put options by funds: $411K
26% less capital invested
Capital invested by funds: $290M → $214M (-$76.3M)
42% less repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 53
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$3.53M |
| 2 |
BlackRock
New York
|
+$1.46M |
| 3 |
Renaissance Technologies
New York
|
+$1.28M |
| 4 |
BMO
Beck Mack & Oliver
New York
|
+$641K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$566K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
N
Nuveen
Charlotte,
North Carolina
|
-$1.77M |
| 2 |
State Street
Boston,
Massachusetts
|
-$1.5M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$978K |
| 4 |
Wells Fargo
San Francisco,
California
|
-$716K |
| 5 |
Two Sigma Investments
New York
|
-$678K |
MDXG Hedge Fund Activity: Q2 2022 in Review
153 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in MiMedx Group (MDXG) for Q2 2022, worth a combined $214M — down 26% from $290M a quarter earlier.
Buyers outnumbered sellers: 20 funds opened new MDXG positions and 13 closed out — a net gain of 7 holders — while 31 added to existing stakes and 53 trimmed.
The largest buyer was Federated Hermes, adding an estimated $3.53M. The largest seller was Nuveen, cutting an estimated $1.77M.
- 153 institutional investors held MiMedx Group (MDXG) as of Q2 2022, up from 150 in Q1 2022.
- Funds reported $214M of MiMedx Group stock for Q2 2022, down 26% quarter-over-quarter.
- 20 funds opened new MiMedx Group positions in Q2 2022 and 13 closed out, a net change of +7 holders.
- The largest MiMedx Group buyer in Q2 2022 was Federated Hermes, an estimated $3.53M added.
- The largest MiMedx Group seller in Q2 2022 was Nuveen, an estimated $1.77M sold.
Based on aggregated 13F filings for Q2 2022.